Review Article

α 2-Adrenoceptors: Challenges and Opportunities—Enlightenment from the Kidney

Figure 2

Signaling mechanisms in the SHR renal microcirculation. Renal sympathetic nerves release norepinephrine which stimulates α2-adrenoceptors (α2-ARs) in renal vascular smooth muscle cells, thus leading to dissociation of Gi and release of αi and βγ subunits. Angiotensin II engages type 1 angiotensin II receptors (AT1-Rs) which results in the release of αq from Gq. βγ subunits arising from Gi-coupled α2-ARs bind receptor for activated C kinase 1 (RACK1) and localize this scaffolding protein to the cell membrane. At the cell membrane, RACK1 also binds phospholipase C (PLC) and protein kinase C (PKC), and PLC binds αq. Together, these interactions result in an efficient signaling complex in which activation of PLC by αq is enhanced by the simultaneous binding of βγ subunits to PLC. Thus, PLC serves as a coincident detector, whereas RACK1 functions here to bring together the stimulating components of this coincident signaling mechanism. This coincident signaling mechanism is further amplified by the fact that RACK1 localizes PLC with PKC, thus facilitating the activation of PKC, which mediates contraction of vascular smooth muscle cells. In addition to βγ-mediated signaling, release of αi by α2-ARs inhibits the adenylate cyclase/cAMP pathway, which further increases contraction of vascular smooth muscle cells. Because of the increased pool of Gi-coupled α2-ARs, both the αi-mediated and βγ-mediated mechanisms are more engaged in the SHR renal microvasculature, thus leading to renal vasoconstriction, sodium retention, and hypertension. The model was tested using pressor levels of angiotensin II with renovascular responses (or in some experiments contractile responses to isolated preglomerular vascular smooth muscle cells) as the outcome measure and, therefore, applies to sympathetic regulation of renal vascular smooth muscle cells; however, we hypothesize that similar coincident signaling involving α2-ARs may occur in renal epithelial cells and may contribute directly to sodium retention and hypertension independent of renovascular changes.